![](https://ml.globenewswire.com/media/23a9d0e4-6c22-4509-971e-0c09c45ec985/small/trinity-biotech-plc-logo.jpg)
Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with ...
-Second Quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over year growth- -Reiterating financial guidance of approximately $20 million of annualized run-rate EBITDASO1 on annualized run-rate …